These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37173697)
1. 'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England. Riley F; Harris M; Poulter HL; Moore HJ; Ahmed D; Towl G; Walker T Harm Reduct J; 2023 May; 20(1):66. PubMed ID: 37173697 [TBL] [Abstract][Full Text] [Related]
2. More than just 'free heroin': Caring whilst navigating constraint in the delivery of diamorphine assisted treatment. Poulter HL; Walker T; Ahmed D; Moore HJ; Riley F; Towl G; Harris M Int J Drug Policy; 2023 Jun; 116():104025. PubMed ID: 37062231 [TBL] [Abstract][Full Text] [Related]
3. Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK. Poulter HL; Moore HJ; Ahmed D; Riley F; Walker T; Harris M Int J Drug Policy; 2024 Apr; 126():104367. PubMed ID: 38460217 [TBL] [Abstract][Full Text] [Related]
4. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885 [TBL] [Abstract][Full Text] [Related]
5. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review. McNair R; Monaghan M; Montgomery P Drug Alcohol Depend; 2023 Jun; 247():109869. PubMed ID: 37086659 [TBL] [Abstract][Full Text] [Related]
6. Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting. Klimas J; Dong H; Fairbairn N; Socías E; Barrios R; Wood E; Kerr T; Montaner J; Milloy MJ Addict Sci Clin Pract; 2018 Feb; 13(1):3. PubMed ID: 29409539 [TBL] [Abstract][Full Text] [Related]
7. Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series. Vogel M; Köck P; Strasser J; Kalbermatten C; Binder H; Dürsteler KM; Walter M; Falcato L; Krausz M; Kormann A Eur Addict Res; 2022; 28(1):80-86. PubMed ID: 34311466 [TBL] [Abstract][Full Text] [Related]
8. Craving and illicit heroin use among patients in heroin-assisted treatment. Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805 [TBL] [Abstract][Full Text] [Related]
11. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. Carroll JJ; Marshall BDL; Rich JD; Green TC Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864 [TBL] [Abstract][Full Text] [Related]
12. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. Fischer B; Oviedo-Joekes E; Blanken P; Haasen C; Rehm J; Schechter MT; Strang J; van den Brink W J Urban Health; 2007 Jul; 84(4):552-62. PubMed ID: 17562183 [TBL] [Abstract][Full Text] [Related]
13. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. Randesi M; van den Brink W; Levran O; Blanken P; Butelman ER; Yuferov V; da Rosa JC; Ott J; van Ree JM; Kreek MJ Drug Alcohol Depend; 2016 Nov; 168():164-169. PubMed ID: 27664554 [TBL] [Abstract][Full Text] [Related]
14. Problematizing the DSM-5 criteria for opioid use disorder: A qualitative analysis. Boyd S; Ivsins A; Murray D Int J Drug Policy; 2020 Apr; 78():102690. PubMed ID: 32278265 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study. Myklebust LH; Eide D; Arnevik EA; Dadras O; De Pirro S; Ellefsen R; Fadnes LT; Hesse M; Kvamme TL; Melis F; Oldervoll A; Thylstrup B; Wusthoff LEC; Clausen T BMC Health Serv Res; 2024 Mar; 24(1):398. PubMed ID: 38553691 [TBL] [Abstract][Full Text] [Related]
16. Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials. Smart R; Reuter P Addiction; 2022 Mar; 117(3):518-531. PubMed ID: 34105206 [TBL] [Abstract][Full Text] [Related]
17. Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver. Boyd S; Murray D; ; MacPherson D Harm Reduct J; 2017 May; 14(1):27. PubMed ID: 28521781 [TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study. Vogel M; Meyer M; Westenberg JN; Kormann A; Simon O; Salim Hassan Fadlelseed R; Kurmann M; Bröer R; Devaud N; Sanwald U; Baumgartner S; Binder H; Strasser J; Krausz RM; Beck T; Dürsteler KM; Falcato L Harm Reduct J; 2023 Jan; 20(1):2. PubMed ID: 36611162 [TBL] [Abstract][Full Text] [Related]
19. Heroin-assisted treatment of heroin-addicted patients normalizes regulatory T cells but does not restore CD4 Hansen W; Luppus S; Barthel R; Chang DI; Broemstrup J; Zwarg T; Shibata J; Westendorf AM; Buer J; Scherbaum N Addict Biol; 2021 Jul; 26(4):e12998. PubMed ID: 33336491 [TBL] [Abstract][Full Text] [Related]